Physician
Igal Khorshidi, M.D., P.C.
Igal Khorshidi, M.D., P.C. was paid $1.40M by Medicaid between Jan 2018 and Nov 2024, across 26 billing codes. Its largest line is 43239, Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple — 37% of everything it billed.
33Billing provider infoIGAL KHORSHIDI, M.D., P.C.
ELMHURST, NY 11373
ELMHURST, NY 11373
33aNPI1871930073assigned 05/29/2013
33bProvider typeGastroenterology Physician
28Total paid$1.40M
24GClaims21,415
24DCodes billed26
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Gastroenterology Physician providers in New York
Rank by total paid#40 of 656
Median peer was paid$12K
This provider vs. median115×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,357 | $464K | |
| 2019 | 4,285 | $235K | |
| 2020 | 2,525 | $116K | |
| 2021 | 1,983 | $86K | |
| 2022 | 2,488 | $140K | |
| 2023 | 2,466 | $225K | |
| 2024incomplete | 1,311 | $139K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 37% | 1,806 | 1,802 | $513K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 17% | 3,951 | 3,795 | $239K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 14% | 1,574 | 1,573 | $192K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 8.5% | 1,409 | 1,389 | $120K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 6.4% | 273 | 270 | $90K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 3.7% | 314 | 277 | $52K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 3.2% | 516 | 516 | $45K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.3% | 816 | 791 | $32K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.8% | 2,100 | 1,930 | $25K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 1.3% | 261 | 261 | $18K |
| 88342 | <1% | 159 | 158 | $12K | |
| 99072 | <1% | 423 | 313 | $12K |
14 more codes
| 88341 | <1% | 144 | $9K | |
| 88313 | <1% | 157 | $8K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 390 | $8K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 294 | $5K |
| A4550 | Surgical trays | <1% | 2,230 | $5K |
| 88312 | <1% | 113 | $4K | |
| 36000 | <1% | 2,174 | $3K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 99 | $3K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 22 | $3K |
| 45331 | <1% | 12 | $2K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,811 | $2K |
| 81025 | <1% | 308 | $1K | |
| 99051 | <1% | 46 | $54.20 | |
| J2704 | Injection, propofol, 10 mg | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKHORSHIDI, IGAL (PRESIDENT)